Tandem Diabetes Care Announces Upcoming Conference Participation
Tandem Diabetes Care (TNDM) has announced its participation in multiple investor conferences in November 2024. The company will present updates at the UBS Global Healthcare Conference (Nov 14), Stifel Healthcare Conference (Nov 19), Jefferies London Healthcare Conference (Nov 20), and Wolfe Research Healthcare Conference (Nov 20). Additionally, they will host meetings at the Canaccord Genuity MedTech Forum (Nov 21). All presentations will be webcast live with 30-day archive access through Tandem's Investor Center website.
Tandem Diabetes Care (TNDM) ha annunciato la sua partecipazione a molteplici conferenze per investitori nel novembre 2024. L'azienda presenterà aggiornamenti alla Conferenza Sanitaria Globale UBS (14 novembre), alla Conferenza Sanitaria Stifel (19 novembre), alla Conferenza Sanitaria di Londra Jefferies (20 novembre) e alla Conferenza Sanitaria Wolfe Research (20 novembre). Inoltre, ospiteranno incontri al Forum MedTech di Canaccord Genuity (21 novembre). Tutte le presentazioni saranno trasmesse in diretta streaming con accesso all'archivio per 30 giorni attraverso il sito dell'Investor Center di Tandem.
Tandem Diabetes Care (TNDM) ha anunciado su participación en múltiples conferencias para inversores en noviembre de 2024. La empresa presentará actualizaciones en la Conferencia Global de Salud UBS (14 de noviembre), en la Conferencia de Salud Stifel (19 de noviembre), en la Conferencia de Salud de Londres Jefferies (20 de noviembre) y en la Conferencia de Salud Wolfe Research (20 de noviembre). Además, organizarán reuniones en el Foro MedTech de Canaccord Genuity (21 de noviembre). Todas las presentaciones se transmitirán en vivo con acceso al archivo durante 30 días a través del sitio web del Centro de Inversores de Tandem.
탠덤 다이아베틱스 케어 (TNDM)는 2024년 11월에 여러 투자자 회의에 참여한다고 발표했습니다. 이 회사는 UBS 글로벌 헬스케어 컨퍼런스 (11월 14일), 스티펠 헬스케어 컨퍼런스 (11월 19일), 제프리즈 런던 헬스케어 컨퍼런스 (11월 20일) 및 울프 리서치 헬스케어 컨퍼런스 (11월 20일)에서 업데이트를 발표할 것입니다. 또한, 카나코드 제뉴이티 메드텍 포럼 (11월 21일)에서 회의를 주최할 예정입니다. 모든 발표는 라이브로 방송되며, 탠덤의 투자자 센터 웹사이트를 통해 30일간 아카이브에 접근할 수 있습니다.
Tandem Diabetes Care (TNDM) a annoncé sa participation à plusieurs conférences pour investisseurs en novembre 2024. L'entreprise présentera des mises à jour lors de la Conférence Globale de Santé UBS (14 novembre), de la Conférence de Santé Stifel (19 novembre), de la Conférence de Santé de Londres Jefferies (20 novembre) et de la Conférence de Santé Wolfe Research (20 novembre). De plus, ils organiseront des réunions lors du Forum MedTech de Canaccord Genuity (21 novembre). Toutes les présentations seront diffusées en direct avec un accès aux archives pendant 30 jours via le site Web du Centre des Investisseurs de Tandem.
Tandem Diabetes Care (TNDM) hat seine Teilnahme an mehreren Investorenkonferenzen im November 2024 bekannt gegeben. Das Unternehmen wird Updates auf der UBS Global Healthcare Conference (14. November), der Stifel Healthcare Conference (19. November), der Jefferies London Healthcare Conference (20. November) und der Wolfe Research Healthcare Conference (20. November) präsentieren. Zusätzlich werden sie Meetings beim Canaccord Genuity MedTech Forum (21. November) abhalten. Alle Präsentationen werden live übertragen und sind über 30 Tage im Archiv auf der Investor Center-Website von Tandem zugänglich.
- None.
- None.
- UBS Global Healthcare Conference on Thursday, November 14, 2024 at 11:45am Eastern Time (8:45am Pacific Time),
- Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024 at 11:30am Eastern Time (8:30am Pacific Time),
- Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 4:30pm GMT (11:30am ET, 8:30am PT), and
- Wolfe Research Healthcare Conference on Wednesday, November 20, 2024 at 8:40am Eastern Time (5:40am Pacific Time).
In addition, the Company will host meetings at the 2024 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 21, 2024.
The presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcasts and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in
Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030276890/en/
Media Contact:
858-366-6900
media@tandemdiabetes.com
Investor Contact:
858-366-6900
IR@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
FAQ
What investor conferences will Tandem Diabetes Care (TNDM) attend in November 2024?
How can investors access Tandem Diabetes Care's (TNDM) conference presentations in November 2024?
When is Tandem Diabetes Care (TNDM) presenting at the UBS Global Healthcare Conference 2024?
What time is Tandem Diabetes Care's (TNDM) presentation at the Jefferies London Healthcare Conference 2024?
